èšåºæ®µéã®ãã€ãªå»è¬åäŒæ¥ã§ãã Fulcrum Therapeutics, Inc. ã¯ãç±³åœã§å»çããŒãºãæºããããŠããªãåéã«ãããŠãéºäŒçã«å®çŸ©ãããçŸæ£ãæã€æ£è
ã®çæŽ»ãæ¹åãã補åã®éçºã«æ³šåããŠããŸããå瀟ã®è£œååè£ã¯ãé¡é¢è©ç²äžè
åçãžã¹ãããã£ãŒã®æ²»çãç®çãšãã第 2b çžèšåºè©Šéšäžã®å°ååã§ãããã¹ããã¢ãã§ããé¡é¢è©ç²äžè
åçãžã¹ãããã£ãŒã¯ãé倧ãªèº«äœé害ãé害ã«ã€ãªãããé²è¡æ§ã§é害ãåŒãèµ·ããçšãªçèçž®æ§çŸæ£ã§ãããŸããéç¶èµ€è¡ççã β ãµã©ã»ãã¢ã®æ£è
ã®èå
ãã¢ã°ããã³ãã¢ããã¬ã®ã¥ã¬ãŒã·ã§ã³ããããã«èšèšãããå°ååã§ãã FTX-6058 ã§ããå瀟ã¯ãŸããçèãäžæ¢ç¥çµç³»ãè¡æ¶²çŸæ£ãå¿ççãèºçŸæ£ã®æ²»çã®ããã®è¬ç©ã¿ãŒã²ãããçºèŠããŠããŸãã Fulcrum Therapeutics, Inc. ã¯ãèºçŸæ£é åã«ãããæšçé©å¿çã«é¢é£ããç¹å®ã®çµè·¯ã調ç¯ããããã®çç©åŠçæšçãç¹å®ããããã«ãAcceleron Pharma Inc. ãšç ç©¶ããã³çºèŠã®ååå¥çŽãçµãã§ããŸãããŸããéºäŒæ§å¿ççã®æ²»çã®ããã®æ°ããæšççæ³ãçºèŠãéçºãåååããããã«ãMyoKardia, Inc. ãšæŠç¥çååããã³ã©ã€ã»ã³ã¹å¥çŽãçµãã§ããŸããFulcrum Therapeutics, Inc. 㯠2015 幎ã«èšç«ãããããµãã¥ãŒã»ããå·ã±ã³ããªããžã«æ¬ç€Ÿã眮ããŠããŸãã